Blog - Page 4056 of 5386

MondayNov 03, 2008 5:54 am

Dendreon Corporation (NASDAQ: DNDN)

Dendreon Corporation (NASDAQ: DNDN), a biotechnology company, is focused on targeting cancer and transforming lives through the discovery, development and commercialization of therapeutics. The Company leverages its staff’s expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates that stimulate an immune response. Additionally, Dendreon is developing an orally-available small molecule that targets Trp-p8, which could applicable to multiple types of cancer as well as benign prostatic hyperplasia. For further information, visit the Company's web site at www.dendreon.com.

MondayNov 03, 2008 5:53 am

Delta Petroleum Corporation (NASDAQ: DPTR)

Delta Petroleum Corporation (NASDAQ: DPTR), a Denver, Colorado based independent energy company, is focused on exploring for, acquiring, developing, and producing natural gas and crude oil. The company has significant leaseholds in the Columbia River Basin in eastern Washington, a prospective frontier resource province. Delta’s strategy is to grow proven reserves and production through development drilling and acquisitions. For further information, visit the Company's web site at www.deltapetro.com.

MondayNov 03, 2008 5:52 am

DelSite Biotechnologies, Inc. (OTC BB: DSII)

DelSite Biotechnologies, Inc. (OTC BB: DSII), an ISO 9001-certified, research-based, biopharmaceutical and consumer products company, has a core technology based on naturally-occurring complex carbohydrates. The company is focused on manufacturing and marketing consumer products as well as manufacturing quality products for other companies. Its proprietary GelSite(r) technology is protected by more than 130 patents in 26 countries. For further information, visit the Company's web site at www.delsite.com.

MondayNov 03, 2008 5:52 am

Delphi Energy Corp. (TSX: DEE CN)

Delphi Energy Corp. (TSX: DEE CN), a Calgary-based public junior oil and natural gas company, has concentrated its efforts on northwestern Alberta and northeast British Columbia. The company is poised for organic growth with a large inventory of development opportunities complemented by a high-impact exploration program. Delphi is led by a team of experienced executives and board of directors, all of which are shareholders focused on efficient share-value growth. For further information, visit the Company's web site at www.delphienergy.ca.

MondayNov 03, 2008 5:51 am

Dejour Enterprises, Ltd. (AMEX: DEJ)

Dejour Enterprises, Ltd. (AMEX: DEJ) is an active micro cap oil and natural gas explorer and producer focused on strategically assembling and developing North American energy properties. The company has 149,852 net acres of premium energy assets in two of North America’s most prolific areas. Dejour’s flagship properties cover 128,000 net acres in the U.S. Rocky Mountains and 21,852 net acres in Canada’s Peace River Arch. For further information, visit the Company's web site at www.dejour.com.

MondayNov 03, 2008 5:47 am

Delcath Systems, Inc. (NASDAQ: DCTH)

Delcath Systems, Inc. (NASDAQ: DCTH), a medical technology company specializing in cancer treatment, is currently testing a proprietary, patented drug delivery system designed to treat liver cancers. The company is enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. Twenty-eight international patents consist of the Company's intellectual property portfolio. For further information, visit the Company's web site at www.delcath.com.

MondayNov 03, 2008 5:46 am

CytRx Corporation (NASDAQ: CYTR)

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company, is focused on developing high-value human therapeutics. Their drug development pipeline includes six programs in clinical development. The Company owns and operates a research and development facility in San Diego, California, and holds a 45% equity interest in RXi Pharmaceuticals (NasdaqCM: RXII ). For further information, visit the Company's web site at www.cytrx.com.

MondayNov 03, 2008 5:45 am

Cytori Therapeutics, Inc. (NASDAQ: CYTX)

Cytori Therapeutics, Inc. (NASDAQ: CYTX) is committed to becoming the global leader in regenerative medicine. The company focuses on providing patients with new options for reconstructive and aesthetic surgery, developing treatments for cardiovascular disease, and banking adipose-derived, adult stem and regenerative cells (ADRCs). To meet its objective, Cytori developed Celution® Technology to separate and concentrate a patient’s own ADRCs for delivery back to the same patient in a single surgical procedure. For further information, visit the Company's web site at www.cytoritx.com.

MondayNov 03, 2008 5:45 am

Targanta Therapeutics Corporation (NASDAQ: TARG)

Targanta Therapeutics Corporation (NASDAQ: TARG), a biopharmaceutical company, is dedicated to developing and commercializing innovative antibiotics that treat serious infections in the hospital and other institutional settings. The company’s lead antibiotic, oritavancin, is designed to treat serious gram-positive bacterial infections, including complicated skin and skin structure infections, or cSSSI, and bacteremia, a blood stream infection. Additionally, Targanta is developing multiple antibacterial agents, including an oral version of oritavancin targeting Clostridium difficile-related conditions. For further information, visit the Company's web site at www.targanta.com.

MondayNov 03, 2008 5:44 am

Cytomedix, Inc. (AMEX: GTF)

Cytomedix, Inc. (AMEX: GTF), a biotechnology company, is focused on developing, selling and licensing regenerative biological therapies. Their AutoloGel(tm) System, a device used to produce platelet rich plasma gel derived from the patient's own blood, has been cleared by the Food and Drug Administration (``FDA'') for use on a variety of exuding wounds. Currently, the Company is executing a multi-faceted strategy to infiltrate the chronic wound market with its AutoloGel(tm) System. For further information, visit the Company's web site at www.cytomedix.com

Site Search

Company Search